Miracle Mile Advisors’s Ocular Therapeutix OCUL Stock Holding History

Miracle Mile Advisors’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$197K	Buy	+20,018	New	+$181K	﹤0.01%	973

Other funds holding OCUL

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

RZH

Relyea Zuckerberg Hanson Stamford, Connecticut $1.2B AUM 28.45% 1-Year Est. Return

UBP

Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

Miracle Mile Advisors's OCUL Position: Q2 2026 in Review

Miracle Mile Advisors opened a new position in Ocular Therapeutix (OCUL) in Q2 2026: 20,018 shares worth $197K. The stake represents ﹤0.01% of the portfolio and ranks #973 among its holdings.

29 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

Miracle Mile Advisors held 20,018 shares of Ocular Therapeutix worth $197K as of Q2 2026.
Ocular Therapeutix was a new Miracle Mile Advisors position in Q2 2026.
Ocular Therapeutix made up ﹤0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #973 holding.
29 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.